Author:
Aylin Yılmaz Emine,Özdemir Öner
Abstract
The World Health Organization declared the current pandemic, known as severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) infection, which began in China in December 2019. SARS-CoV-2 has the third highest recorded pathogenicity, with mortality rates varying from 6 to 10.5% based on comorbidity of the individual infected with the virus. Epidemiologic studies have critical importance in the fight against any disease. This chapter discusses demographic and epidemiologic literature data including age, gender, reinfection, death, and vaccination rates reported in numerous articles during the pandemic process from Türkiye.
Reference27 articles.
1. Kouhpayeh S, Shariati L, Boshtam M, Rahimmanesh I, Mirian M, Zeinalian M, et al. The molecular story of COVID-19; NAD+ depletion addresses all questions in this infection. Preprints. 2020:2020030346. DOI: 10.20944/preprints202003.0346.v1
2. Lombardy Section Italian Society Infectious and Tropical Diseases.Vademecum for the treatment of people with COVID-19. Edition 2.0, 13 March 2020. Le Infezioni in Medicina. 1 Jun 2020;28(2):143-152. PMID: 32275256 [Ahead of print]
3. O’Driscoll M, Ribeiro Dos Santos G, Wang L, Cummings DAT, Azman AS, Paireau J, et al. Age-specific mortality and immunity patterns of SARS-CoV-2. Nature. 2021;590(7844):140-145. DOI: 10.1038/s41586-020-2918-0
4. Zhang H, Penninger JM, Li Y, Zhong N, Slutsky AS. Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: Molecular mechanisms and potential therapeutic target. Intensive Care Medicine. 2020;46(4):586-590. DOI: 10.1007/s00134-020-05985-9
5. Meyerowitz EA, Richterman A, Gandhi RT, Sax PE. Transmission of SARS-CoV-2: A review of viral, host, and environmental factors. Annals of Internal Medicine. Jan 2021;174(1):69-79. doi: 10.7326/M20-5008